Inspire Medical Systems INSP recently showcased new clinical data, technology advancements and cardiovascular outcomes ...

Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance.

The biotech’s LSD recipe, known as DT120 ODT, scored wins on all primary and key secondary endpoints of the 149-patient Emerge trial, Definium announced Monday, June 22, marking a reduction in ...

Orbis serves as the intelligence layer connecting ICON's clinical, operational, and enterprise data. The Microsoft ...

Critical Path Institute® (C-Path), through its Type 1 Diabetes Consortium, today reaffirmed its commitment to strengthening ...

NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data from its Phase 2 ...

Complete SAFE KIDNEY II data confirm sustained reduction in viral load and resolution of biopsy-proven BKPyV-associated nephropathy with continued antiviral effect to 38 weeks Systematic literature ...

Managing non-EDC (Electronic Data Capture) data integration in clinical trials is a challenge that holds significant promise. As clinical studies continue to draw on data from wearable devices like ...

AI in clinical trials holds great promise for the entire drug development lifecycle. However, any new technology should ...

Last week Danish pharmaceutical company Novo Nordisk, the maker of the popular diabetes and weight-loss drugs Ozempic and ...

The data is pseudonymous and apparently can't be linked to actual people.

Hackers claim they stole 1.3TB of Novo Nordisk data, including clinical trial and AI model information, after issuing a $25 million demand.